Sunday, June 21, 2020

COVID-19 | Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir

COVID-19 | Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir Remdesivir, administered in the form of injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for five days.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-|-hetero-cipla-get-nod-to-manufacture-market-antiviral-drug-remdesivir_13932981.html

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...